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Abstract Hepatitis C (HCV) is very prevalent among injecting drug users (IDU). Control 
of this infection poses a major challenge to harm reduction services. Education of all IDU 
regarding HCV constitutes part of the harm reduction programme. We sought to assess 
understanding of HCV among IDU attending an addiction treatment clinic and to identify 
whether or not those with increased contact with health professionals demonstrated better 
understanding. 105 IDU were interviewed to assess their knowledge regarding modes of 
transmission and chronicity of HCV infection. They had first injected an average of 10.0 years 
previously. Interviewees were more successful at identifying activities which carried a risk of 
HCV transmission than they were at identifying activities which posed no risk of infection. 
Over one third falsely believed that one could contract HCV infection even when injecting 
‘safely’. Understanding of the long term nature of HCV infection was also impaired. A group 
on methadone maintenance for a median period of 1.4 years failed to demonstrate significantly 
better knowledge than those attending for a 21-day detoxification. Those in frequent contact 
with a GP performed less well than those without such contact. Understanding of HCV among 
IDU is inadequate and must improve if primary prevention efforts are to succeed. We question 
the value of didactic approaches to educating IDU and call for a more experiential teaching 
style which may be more successful at countering prevalent misconceptions. 
Smyth BP, McMahon J, O’Connor JJ and Ryan (1999) Knowledge regarding Hepatitis C among injecting drug users, Drugs: 
Education, Prevention and Policy, 6(2), 257- 264 
  3 
Introduction 
World-wide, infection with hepatitis C ( HCV ) is common among injecting drug users ( IDU) 
(MacDonald et al, 1996; Wodak & Crofts, 1996; Thomas et al, 1995). Although UK IDU have 
demonstrated a reduction in risk behaviour ( Griffin et al, 1993; Stimson & Hunter, 1996), the 
prevalence of this infection remains high in injectors who commenced injecting in the current 
era of harm reduction (Smyth et al, 1995). Some commentators have become quite sceptical 
about the prospect of reducing rates of HCV among IDU (Wodak & Crofts, 1996). 
Internationally, harm reduction efforts include the provision of sterile injecting equipment and 
treatment with methadone. Education regarding safe injecting and, the dangers of unsafe 
injecting such as HIV and HCV, is another crucial component and occurs in treatment settings 
and through community outreach. All of these approaches are currently in existence in Dublin. 
At this point in time there has been no public health awareness campaign targeting hepatitis C. 
Therefore, IDU in Dublin are likely to have acquired information about hepatitis C from one of 
two main sources; health professionals and via peers (Wolitski et al, 1996; Barendregt & 
Trautmann, 1996). Health professionals include general practitioners and staff working in 
specialist addiction treatment centres. The effectiveness of health professionals attempts to 
educate IDU regarding HCV has not previously been assessed. If inadequate, it may account in 
part for the ongoing high incidence of HCV. 
 
HCV is thought to be spread very readily via sharing needles and syringes. Sexual transmission 
and vertical transmission can also occur, although the level of risk associated with each of these 
circumstances is less. Now that blood products are screened for HCV, the risk of infection via 
blood transfusion is very much reduced, but is not zero. Up to 90% of infected persons are 
thought to carry the virus indefinitely. ( Cramp, 1997; Gully, 1997) 
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Two Australian studies have found knowledge of hepatitis C to be lacking among certain out of 
treatment risk groups ( prison inmates and high risk drug users ), although the populations 
studied were not confined to IDU ( Carruthers & Loxley, 1995; Butler et al , 1997). We sought 
to measure IDUs’ level of knowledge regarding HCV in the setting of an addiction treatment 
clinic and to identify factors influencing this knowledge. We anticipated that those with 
increased contact with medical services would demonstrate better understanding, i.e. a ‘dose-
response’ type effect. Also, for those of unknown HCV status, we wished to assess their current 
perceived level of risk of HCV infection. 
 
Patients and Methods 
 
All patients had a history of injecting drug use and a diagnosis of opiate dependence. A 
researcher (JM), who was independent of treatment services, interviewed patients over a five 
week period in August-September 1997. The patient groups eligible for inclusion were (i) those 
who commenced a 21-day methadone detoxification during the study period and (ii) those 
attending the clinic daily or on alternate days for methadone maintenance at the outset of the 
study. Patients were asked to consent to a confidential, structured interview lasting 30 minutes 
approximately. Due to time constraints, the researcher could not meet all 139 eligible patients 
and consequently 30 ( 22%) were not asked to participate. Four of those who were asked to 
consent to interview refused. The overall participation rate was 75.5%. Those not interviewed 
did not significantly differ in terms of sex ratio or age. Data was collected on socio-
demographics, drug use history, current treatment and contact with general practitioner.  
 
As no standardised instrument exists for assessing patients’ knowledge regarding HCV, we 
developed our own series of questions. A scoring system was also agreed among the research 
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team after consultation with experts in the area of HCV. We chose to focus on two aspects of 
HCV. These were (i) routes of transmission and (ii) chronicity of infection. Regarding routes of 
infection, interviewees were initially asked to identify all routes of transmission which they 
believed could lead to HCV infection without prompting. They were then presented with a list 
of seven possible modes of spread of hepatitis C and asked to identify those which they thought 
were true, false or about which they were unsure. In order to calculate an overall ‘knowledge 
score’ for each interviewee, the following, scoring system was employed. Correct responses 
were scored ‘plus one’, incorrect responses scored ‘minus one’ and ‘don’t knows’ scored zero. 
We believed it to be appropriate to use a ‘negative marking system’ as a false belief was 
considered more hazardous, in terms of the individual contracting and spreading HCV 
infection, than an acknowledgement of being unsure regarding a given mode of possible 
transmission. The two questions on chronicity of infection followed a multiple choice format, 
interviewees being presented with a list of possible answers. Correct responses to each scored 
two points, nearly correct responses scored one point and incorrect responses and ‘don’t 
knows’ scored zero. The maximum possible ‘knowledge score’ was eleven. For all questions, 
interviewees were asked not to guess. Medical terms such as ‘vertical’ were not used during 
questioning with simple lay terminology being substituted. 
 
Results 
 
Seventy-three ( 70% ) of the 105 patients were male. The median age of the group was 29 years 
( range 16 to 48 years). The median period since first injecting was 8 years ( range 0.2 to 30 
years ). Forty-three patients ( 41% ) were on the detoxification programme and 62 ( 59% ) were 
on maintenance. Those on maintenance had been attending for a median period of 1.4 years 
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(range 0.1 to 20 years). Overall 84 ( 80% ) reported previously having had a test for hepatitis C, 
and 75(89%) of these indicated that the result was positive. 
 
In all, 77 ( 73% ) indicated that they were registered with a GP. Of this group, seventy ( 91% ) 
reported that their GP was aware of their drug use and 47 ( 61% ) had seen their GP six or more 
times over the preceding twelve months.  
 
All participants had heard of hepatitis C. Table 1 indicates that the vast majority (90%) 
spontaneously identified sharing injecting equipment as being a risk activity for transmission of 
Hepatitis C. Sexual intercourse and receiving a blood transfusion were the next two most 
frequently reported potential modes of transmission.  
 
Table 1. The proportion of interviewees reporting various methods of transmission of Hepatitis 
C in response to an open-ended question, without prompting. 
 Total 
(n = 105) 
Males 
(n = 73) 
Females 
(n = 32) 
Significance 
test1 
 Number (%) Number (%) Number (%) p 
Sharing Injecting Equipment 95 (90) 67 (92) 28 (88) 0.49 
Sexual Intercourse 49 (47) 35 (48) 14 (44) 0.69 
Receiving a Blood Transfusion 20 (19) 15 (20) 5 (16) 0.55 
Injecting without ever sharing injecting 
equipment 8 (8) 7 (10) 1 (3) 0.43 
Household Spread (Toothbrushes, etc) 8 (8) 7 (10) 1 (3) 0.43 
Kissing 1 (1) 1 (1) 0 (0) 1.0 
Vertical 0 (0) 0 (0) 0 (0) 1.0 
1 Chi squared test was used except where the minimum expected cell count was less than 5, in which case Fisher’s exact test 
statistic was calculated. 
 
Table 2 indicates responses when interviewees were asked directly about specific activities. In 
all, 77(73%) recognised all four of the risk activities (i.e. sharing injecting equipment, sex, 
transfusion and vertical). The proportions responding correctly dropped when asked about 
activities with no recognised risk with only 46(44%) recognising all three ‘safe’ activities ( i.e. 
injecting without sharing, smoking heroin and kissing ). On the issue of chronicity of infection, 
only 46(44%) answered both questions correctly.  
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Table 2  Beliefs held by interviewees regarding specific potential modes of transmission of Hepatitis C 
and responses to questions on chronicity of infection. 
  Correctly 
responding 
Incorrectly 
responding 
Unsure  
  Number (%) Number (%) Number (%) 
        
Identification of activities that pose some level of risk       
 Sharing Injecting Equipment 104 (99) 0 (0) 1 (1) 
 Sexual Intercourse 96 (91) 4 (4) 5 (5) 
 Receiving a Blood Transfusion in the past 96 (91) 4 (4) 5 (5) 
 Vertical 90 (86) 7 (7) 8 (7) 
 All four identified as posing some level of risk 77 (73)     
        
Identification of activities that pose no recognised risk       
 Injecting without ever sharing injecting equipment 59 (56) 39 (37) 7 (7) 
 Only ever smoking heroin 84 (80) 16 (15) 5 (5) 
 Kissing 87 (83) 11 (10) 7 (7) 
 All three identified as posing no risk  46 (44)     
        
“How long does hepatitis C usually stay in the body when 
infected?” 
      
 Days to months   2 (2)   
 Many Years 6 (6)     
 Lifetime 74 (70)     
 Don’t Know     23 (22) 
        
“How many people with hepatitis C will have infection for 
years?” 
      
 10% or less   10 (9)   
 About 1 in 3 1 (1)     
 More than half (more than 50%) 51 (49)     
 Don’t know     43 (41) 
 Both questions on ‘chronicity’ answered correctly 46 (44)     
 
Over one third incorrectly believed that one could contract HCV while injecting safely, i.e. 
when no sharing of any injecting equipment or associated paraphernalia occurred ( table 2). 
Those who believed this were subsequently questioned about how this might occur to ensure 
that they were not misunderstanding the question. Theories about this mode of transmission 
varied but included; “if your own blood is exposed to the air when you draw back, you can get 
it”, “its on your skin and once you push the needle through, you get it” or “it can just be in the 
gear [heroin]”. 
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Regarding the overall ‘knowledge score’, these ranged from minus 1 to 11 ( mean 7.60, median 
8 ). Only 18(17%) of interviewees responded correctly to all questions. Table 3 shows the 
relationship between the mean ‘knowledge score’ and various independent variables. Older age 
and longer history of injecting were each associated with significantly better scores (p<0.01). 
(It must be noted that the groupings for age and duration injecting are very significantly 
associated, those of older age tending also to have longer injecting histories [chi squared =33.9, 
p<0.001]). Those in frequent contact with a GP did significantly worse than those without such 
contact (p=0.02). Neither younger interviewees nor those with shorter injecting histories were 
over-represented in the group with frequent GP contact ( data not shown, chi squared test, 
p=0.73 and 0.74 respectively). Gender, remaining longer in education, employment status, 
having previously been tested for HCV and being on the maintenance programme were not 
significantly associated with better scores. 
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Table 3 Mean ‘Knowledge scores’ attained by interviewees regarding hepatitis C and their association 
with socio-demographic, drug use and treatment characteristics. 
  
Number 
Mean 
‘Knowledge 
score’ 
Standard 
Deviation 
Student’s t 
statistic1 
Degrees 
of 
freedom P value 
        
Total Group 105 7.60 2.61    
        
Gender       
 Male 73 7.64 2.45    
 Female 32 7.50 2.99 0.259 103 0.80 
        
Age (years)2       
 Less than 30  54 6.89 2.72    
 30 and over 51 8.35 2.28 -2.978 103 0.004 
        
School leaving age (years) 2       
 Less than 15  52 7.98 2.24    
 15 and over 53 7.23 2.90 1.489 103 0.14 
        
Employment status3       
 Employed 15 7.67 2.47    
 Unemployed 89 7.62 2.65 0.066 102 0.95 
        
Duration injecting(years) 2       
 Less than 8  47 6.70 2.61    
 8 and over 58 8.33 2.39 -3.321 103 0.001 
        
Hepatitis C testing       
 Previously tested 84 7.80 2.73    
 Never tested 21 6.81 1.91 1.562 103 0.12 
        
Treatment Programme       
 Maintenance 62 7.84 2.56    
 Detoxification 43 7.26 2.67 1.126 103 0.26 
        
Frequent Attender of GP4       
 Yes 45 6.93 2.85    
 No 60 8.10 2.32 -2.312 103 0.02 
        
1 Independent samples T-test performed. Levene’s test for equality of variances supported validity of use of T-test 
in each case 
2 For the purposes of data presentation and statistical analysis, quantitative variables were categorised according to 
their median value. 
3 One interviewee was still attending school. 
4 Attending a GP more than 5 times in the preceding 12 months considered ‘frequent’.  
 
Of the 21 never previously tested for HCV, only five thought it likely or very likely that they 
were currently infected.  
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Discussion 
 
This study has some limitations. Firstly, only 75.5% of the available study population were 
interviewed due to time constraints imposed on the number of weeks during which the 
interviewer could attend the clinic. However, we believe that it is unlikely that any sampling 
bias was inherent in this process. The study population is modest in size and hence limited the 
power to detect possible independent variable which exert a minor effect on knowledge 
enhancement. Also in this study population, the mean age is greater and mean length of 
injecting history longer than the corresponding figures from the national statistics on 
attendances for treatment of drug misuse ( Moran et al, 1997.). This suggests that the level of 
knowledge demonstrated in this study is greater than one would expect of the typical IDU 
attending for treatment in Dublin. Also, we did not attempt to assess understanding of the 
various degrees of risk associated with activities, sharing of injecting equipment obviously 
carrying with it a much greater level of risk than sexual intercourse, for example. The use of 
face to face interviews, which were conducted by a member of the research team with clinical 
training, ensured that misunderstanding of questions by interviewees was kept to a minimum.  
 
Encouraging findings included the fact that all had heard of HCV and knowledge of the risk 
activities which may lead to its transmission were satisfactory. This was not the case in the two 
Australian populations previously studied and may indicate the beneficial impact of contact 
with treatment services. However, greater confusion was demonstrated when it came to 
identifying those activities which posed no risk of HCV. We are concerned at the finding that 
substantial minorities believe that there is risk of exposure even when not sharing any injecting 
paraphernalia and when only smoking heroin. Perceived personal vulnerability to infections 
such as HCV is likely to be a factor in leading individuals to avoid practising unsafe injecting 
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(Caruthers, 1995). If this vulnerability is diminished by a false belief that one may already have 
been exposed to HCV when injecting safely or when smoking, the preparedness to share 
injecting equipment may well increase. Hence such misconceptions may facilitate spread of 
HCV and HIV. IDUs’ underestimation of their level of risk of exposure to HCV was 
demonstrated and this is a frequent finding in studies of this nature (Caruthers, 1995). 
 
Those participants who were on the maintenance program had been attending for a median 
period of over 500 days. The maximum attendance period for those on the detoxification 
programme prior to interview was 25 days, but was much less in most cases (exact period of 
attendance not recorded for the detoxification group). The fact that those on the maintenance 
program did not know significantly more about HCV suggests that prolonged and ongoing 
contact with a treatment centre is not significantly better in terms of knowledge acquisition than 
a brief contact. The finding that those in regular contact with a GP performed less well than 
those without such contact was surprising. We were unable to identify any confounding 
variable which could explain this observation. Overall, we found no evidence that health 
professional contact and knowledge acquisition demonstrated a positive ‘dose-response effect’. 
 
Conclusion 
 
In this highly treated population of IDU, many still demonstrated prominent misconceptions 
about the ease of transmission and natural history of HCV infection. Simply increasing contact 
with services has not been shown here to lead to any significant gain in understanding. Hence 
one must conclude that current education approaches in specialist treatment centres and by GPs 
have deficits. There may be an inadequate understanding of HCV among drug service workers 
and this could be usefully examined in further studies. Alternatively, rather than a lack of 
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knowledge, there may be inadequacies in the way in which information is provided to IDU. 
Stiernborg (1996) evaluated HIV educational approaches and demonstrated that a didactic 
teaching style is less effective than an experiential style. It may well be the case that as health 
professionals, we are more inclined to give facts to patients about what we know to be the risk 
activities, rather than explore with them what they perceive as risk behaviour. When adopting 
the latter approach, their misconceptions are more likely to emerge and thereby provide the 
clinician with the opportunity to correct and educate. This approach is amenable to group work 
(Stiernborg et al, 1996). If misconceptions are not corrected on contact with health 
professionals, then the potentially useful peer network will only serve to perpetuate 
misinformation (Barendregt & Trautmann, 1996). 
 
We accept that even if all IDU were fully informed, injecting risk behaviour would not cease. 
However, we firmly believe that extensive syringe exchange programmes, without co-existing 
focused education approaches, will fall far short of their potential impact (Strathdee et al, 1997; 
Smith, 1987). There is a need for thoughtful education initiatives, which take into account the 
various myths and misconceptions which are prevalent in each given area world-wide. This 
means moving away from the typical didactic model of fact provision.  
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